Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L., Anti-metastasis therapy: Sirtuin-2 suppresses the expression of PD-1 , a suppressor of activation of T-cells, via down regulation of its target gene, 1/March/2015, 17.04, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: It has recently been shown that blocking PD-1 with antibodies, one could make tumors shrink. This work relating to Cancer immunotherapy has been chosen as Science’s breakthrough of the year. The study presented here suggests that Sirtuin-2, by decreasing the expression of its target gene, it may suppress the expression of PD-1. Thereby, it may activate the immune system and inhibit metastatic progression. Thus, pharmacological formulations encompassing “Sirtuin-2 activators“ may be used to inhibit the progression of tumors.
Amount: $ 500*
Undisclosed information: How Sirtuin-2 decreases the expression of PD-1
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org